Results 161 to 170 of about 3,750 (180)

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis

Arthritis and Rheumatology, 2021
Mehrdad Maz, Sharon A Chung, Gordon Guyatt   +2 more
exaly  

Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica

Nature Reviews Rheumatology, 2020
Dario Camellino, Frank Buttgereit, Christian Dejaco   +2 more
exaly  

Roles of selenoprotein S in reactive oxygen species-dependent neutrophil extracellular trap formation induced by selenium-deficient arteritis

Redox Biology, 2021
Qianru Chi, Yiming Zhang, Shi-Wen Xu
exaly  

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

Annals of the Rheumatic Diseases, 2022
Cristina Ponte, Peter C Grayson, Andrew Judge   +2 more
exaly  

Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities

Nature Reviews Rheumatology, 2017
Christian Dejaco, Elisabeth Brouwer, Justin C Mason   +2 more
exaly  

Visual loss and other cranial ischaemic complications in giant cell arteritis

Nature Reviews Rheumatology, 2017
Alessandra Soriano, Francesco Muratore, Luigi Boiardi   +2 more
exaly  

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

Lancet, The, 2016
Peter M Villiger, Stefan Kuchen, Lukas Bütikofer   +2 more
exaly  

EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria

Annals of the Rheumatic Diseases, 2010
Angela Pistorio, Donato Rigante, Luca Cantarini   +2 more
exaly  

A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis

Arthritis and Rheumatology, 2017
David Cuthbertson, Nader Khalidi, Philip Seo   +2 more
exaly  

Trial of Tocilizumab in Giant-Cell Arteritis

New England Journal of Medicine, 2017
John H Stone, Martin Aringer, Daniel Blockmans   +2 more
exaly